当前位置: X-MOL 学术Haematologica › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia.
Haematologica ( IF 8.2 ) Pub Date : 2024-06-20 , DOI: 10.3324/haematol.2024.285410
Clifford M Csizmar 1 , Mark Gurney 1 , Rashmi Kanagal-Shamanna 2 , Kelly Chien 3 , Danielle Hammond 3 , Terra L Lasho 1 , Christy M Finke 1 , Christopher Dean 1 , Anuya Natu 1 , Abhishek A Mangaonkar 1 , Aref Al-Kali 1 , Naseema Gangat 1 , Ayalew Tefferi 1 , Hassan Alkhateeb 1 , Guillermo Garcia-Manero 3 , Rami S Komrokji 4 , Najla A Ali 4 , Eric Padron 4 , Guillermo Montalban-Bravo 3 , Mrinal M Patnaik 1
Affiliation  

Not available.

中文翻译:


基于 ASXL1/TET2 基因型的风险分层优于 ASXL1 突变的影响,并且独立于慢性粒单核细胞白血病的突变变异等位基因部分。


 无法使用。
更新日期:2024-06-20
down
wechat
bug